BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24288363)

  • 21. Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60-Year-Olds.
    Thiagarajan D; Frostegård AG; Singh S; Rahman M; Liu A; Vikström M; Leander K; Gigante B; Hellenius ML; Zhang B; Zubarev RA; de Faire U; Lundström SL; Frostegård J
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27998914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.
    Fagerberg B; Prahl Gullberg U; Alm R; Nilsson J; Fredrikson GN
    PLoS One; 2015; 10(3):e0120744. PubMed ID: 25768285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes.
    Lopes-Virella MF; Hunt KJ; Baker NL; Virella G;
    J Diabetes Complications; 2016; 30(4):693-9. PubMed ID: 26861948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
    Sjögren P; Fredrikson GN; Samnegard A; Ericsson CG; Ohrvik J; Fisher RM; Nilsson J; Hamsten A
    Eur Heart J; 2008 Sep; 29(18):2218-26. PubMed ID: 18664466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance].
    Zhou ZX; Qiang H; Ma AQ; Chen H; Zhou P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):258-62. PubMed ID: 16706128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy.
    Resch U; Tatzber F; Budinsky A; Sinzinger H
    Br J Clin Pharmacol; 2006 Mar; 61(3):262-74. PubMed ID: 16487219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic syndrome, smoking, and antibodies to oxidized LDL in 58-year-old clinically healthy men.
    Fagerberg B; Bokemark L; Hulthe J
    Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4):227-35. PubMed ID: 11831108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection.
    Yilmaz A; Jennbacken K; Fogelstrand L
    BMC Infect Dis; 2014 Mar; 14():143. PubMed ID: 24636004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
    Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidized low-density lipoprotein levels circulating in plasma and deposited in the tissues: comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction.
    Kayo S; Ohsawa M; Ehara S; Naruko T; Ikura Y; Hai E; Yoshimi N; Shirai N; Tsukamoto Y; Itabe H; Higuchi K; Arakawa T; Ueda M
    Am Heart J; 2004 Nov; 148(5):818-25. PubMed ID: 15523312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.
    Fredrikson GN; Hedblad B; Berglund G; Alm R; Ares M; Cercek B; Chyu KY; Shah PK; Nilsson J
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):872-8. PubMed ID: 12649091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men.
    Sjögren P; Fredrikson GN; Rosell M; de Faire U; Hamsten A; Nilsson J; Hellenius ML; Fisher RM
    Metabolism; 2008 Mar; 57(3):362-6. PubMed ID: 18249208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.
    Fefer P; Tsimikas S; Segev A; Sparkes J; Otsuka F; Kolodgie F; Virmani R; Juliano J; Charron T; Strauss BH
    Cardiovasc Revasc Med; 2012; 13(1):11-9. PubMed ID: 22079685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.
    Grönlund H; Hallmans G; Jansson JH; Boman K; Wikström M; de Faire U; Frostegård J
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):382-6. PubMed ID: 19369878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine in patients with hypertension and myocardial infarction.
    Wu R; Shen G; Morris R; Patnaik M; Peter JB
    J Autoimmun; 2005 Jun; 24(4):353-60. PubMed ID: 15913955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators.
    Bili A; Moss AJ; Francis CW; Zareba W; Watelet LF; Sanz I
    Circulation; 2000 Sep; 102(11):1258-63. PubMed ID: 10982540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.